harvard medical school: "cgrp: a new era for migraine treatment.".

the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�.

..

..

"we had (borrelia miyamotoi) as the new disease for the physicians to be aware of", told rusk..
it also provides 85 per cent accurate prediction results than current methods.